We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Clarify Pharma PLC | AQSE:PSYC | Aquis Stock Exchange | Ordinary Share | GB00BMCD8M81 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.07 | 0.06 | 0.08 | 0.08 | 0.07 | 0.07 | 4,375,000 | 16:29:44 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
22 May 2024
File Forge Technology PLC
(formerly Clarify Pharma PLC)
("File Forge" or the "Company")
Change of name to File Forge Technology Plc
File Forge Technology Plc (AQUIS: FILE) is pleased to announce that, further to its announcement dated 16 April 2024, its change of name to File Forge Technology Plc has now been registered at Companies House and will take effect on the AQSE Exchange from tomorrow, 23 May 2024, at 8.00 a.m.
The Company's ticker symbol, under which its shares are traded on the AQSE Growth Market, will change to "FILE" from tomorrow, 23 May 2024, at 8.00 a.m. The Company confirms that there is no change to the Company's ISIN (GB00BMCD8M81).
The Company's website is https://www.getfileforge.com/
Shareholders will be unaffected by the change of name, and existing share certificates should be retained and remain valid.
The Directors of File Forge accept responsibility for this announcement.
For further information please contact:
File Forge Technologies plc |
|
Jon Bixby Executive Chairman
|
Via First Sentinel +44 7858 888 007 |
First Sentinel |
|
Corporate Adviser Brian Stockbridge
|
+44 7858 888 007 |
1 Year Clarify Pharma Chart |
1 Month Clarify Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions